The effects of methamphetamine self-administration on behavioural sensitization in the olfactory bulbectomy rat model of depression

International Journal of Neuropsychopharmacology

Volumn 15, Issue 10, 2012, Pages 1503-1511

  Kucerova, Jana ^a   Pistovcakova, Jana ^a   Vrskova, Dagmar ^b   Dusek, Ladislav ^a   Sulcova, Alexandra ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

^b UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

Author keywords

Depression; IVSA; methamphetamine; olfactory bulbectomy model; Wistar rats

Indexed keywords

METHAMPHETAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG DEPENDENCE; DRUG EFFECT; DRUG EFFICACY; DRUG SELF ADMINISTRATION; DRUG SENSITIZATION; MALE; NONHUMAN; OLFACTORY BULBECTOMY; PRIORITY JOURNAL; RAT;

ANIMALS; BEHAVIOR, ADDICTIVE; DEPRESSION; DISEASE MODELS, ANIMAL; MALE; METHAMPHETAMINE; OLFACTORY BULB; RATS; RATS, WISTAR; SELF ADMINISTRATION; TREATMENT OUTCOME;

EID: 84867247559     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711001684     Document Type: Article

References (51)

1. Alguacil LF, Salas E, Gonzalez-Martin C (2011). Identification of new drug targets and biomarkers related to obesity and eating disorders : an approach based on reward deficit and addiction. Current Pharmaceutical Design 17, 462-470.
2. Boschloo L, Vogelzangs N, Smit JH, van den Brink W, et al. (2011). Comorbidity and risk indicators for alcohol use disorders among persons with anxiety and/or depressive disorders findings from the Netherlands Study of Depression and Anxiety. Journal of Affective Disorders, 131, 233-242.
3. Cairncross KD, King MG, Schofield SP (1975). Effect of amitriptyline on avoidance learning in rats following olfactory bulb ablation. Pharmacology, Biochemistry, and Behavior 3, 1063-1067.
4. Chambers RA, Sheehan T, Taylor JR (2004). Locomotor sensitization to cocaine in rats with olfactory bulbectomy. Synapse 52, 167-175.
5. Chiang CY, Yeh KY, Lin SF, Hsuchou H, et al. (2008). Effects of alcohol on the mouse-killing behavior of olfactory bulbectomized rats. Chinese Journal of Physiology 51, 408-413.
6. Collins RJ, Weeks JR, Cooper MM, Good PI, et al. (1984). Prediction of abuse liability of drugs using IV self-administration by rats. Psychopharmacology 82, 6-13.
7. Compton WM, Conway KP, Stinson FS, Grant BF (2006). Changes in the prevalence of major depression and comorbid substance use disorders in the United States between 1991-1992 and 2001-2002. American Journal of Psychiatry 163, 2141-2147.
8. Cottencin O (2009). Severe depression and addictions. Encephale 35 (Suppl. 7), S264-S268.
9. Craig W (1917). Appetites and aversions as constituents of instincts. Proceedings of the National Academy of Sciences USA 3, 685-688.
10. Dahlquist G, Björck A (2008). Numerical Methods in Scientific Computing. Philadelphia : Society for Industrial and Applied Mathematics.
11. Davis L, Uezato A, Newell JM, Frazier E (2008). Major depression and comorbid substance use disorders. Current Opinion in Psychiatry 21, 14-18.
12. de Vries TJ, Schoffelmeer AN, Binnekade R, Mulder AH, et al. (1998). Drug-induced reinstatement of heroin-and cocaine-seeking behaviour following long-term extinction is associated with expression of behavioural sensitization. European Journal of Neuroscience 10, 3565-3571.
13. Foltin RW (2005). Effects of dietary and pharmacological manipulations on appetitive and consummatory aspects of feeding in non-human primates. Appetite 45, 110-120.
14. Fukushiro DF, Frussa-Filho R (2010). Chronic amphetamine transforms the emotional significance of a novel but not a familiar environment : implications for addiction. International Journal of Neuropsychopharmacology 14, 955-965.
15. Gan JO, Walton ME, Phillips PE (2010). Dissociable cost and benefit encoding of future rewards by mesolimbic dopamine. Nature Neuroscience 13, 25-27.
16. Hall DH, Queener JE (2007). Self-medication hypothesis of substance use: testing Khantzian's updated theory. Journal of Psychoactive Drugs 39, 151-158.
17. Holmes PV, Masini CV, Primeaux SD, Garrett JL, et al. (2002). Intravenous self-administration of amphetamine is increased in a rat model of depression. Synapse 46, 4-10.
18. Kelly JP, Wrynn AS, Leonard BE (1997). The olfactory bulbectomized rat as a model of depression: an update. Pharmacology and Therapeutics 74, 299-316.
19. Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, et al. (1996). The epidemiology of co-occurring addictive and mental disorders : implications for prevention and service utilization. American Journal of Orthopsychiatry 66, 17-31.
20. Khantzian EJ (1985). The self-medication hypothesis of addictive disorders : focus on heroin and cocaine dependence. American Journal of Psychiatry 142, 1259-1264.
21. Kucerova J, Pistovcakova J, Vrskova D, Sulcova A (2010). Aripiprazole does not influence methamphetamine I. V. self-administration in rats. Activitas Nervosa Superior Rediviva 52, 261-265.
22. Kucerova J, Vrskova D, Sulcova A (2009). Impact of repeated methamphetamine pretreatment on intravenous self-administration of the drug in males and estrogenized or non-estrogenized ovariectomized female rats. Neuroendocrinology Letters 30, 663-670.
23. Kushnir V, Menon M, Balducci XL, Selby P, et al. (2010). Enhanced smoking cue salience associated with depression severity in nicotine-dependent individuals : a preliminary fMRI study. International Journal of Neuropsychopharmacology, doi : 10.1017/S1461145710000696, published online 7 July 2010.
24. Landa L, Slais K, Hanesova M, Sulcova A (2005). Behavioural sensitization to methamphetamine stimulatory effects on locomotion: comparative study in mice and rats. Behavioural Pharmacology 16 (Suppl. 1), S55.
25. Landa L, Slais K, Sulcova A (2008). Impact of cannabinoid receptor ligands on sensitization to methamphetamine effects on rat locomotor behaviour. Acta Veterinaria Brno 77, 183-191.
26. Langas AM, Malt UF, Opjordsmoen S (2010). Comorbid mental disorders in substance users from a single catchment area-a clinical study. BMC Psychiatry 11, 11-25.
27. Leonard BE, Tuite M (1981). Anatomical, physiological, and behavioral aspects of olfactory bulbectomy in the rat. International Review of Neurobiology 22, 251-286.
28. Leventhal AM, Lewinsohn PM, Pettit JW (2008). Prospective relations between melancholia and substance use disorders. American Journal of Drug and Alcohol Abuse 34, 259-267.
29. Lin D, Bruijnzeel AW, Schmidt P, Markou A (2002). Exposure to chronic mild stress alters thresholds for lateral hypothalamic stimulation reward and subsequent responsiveness to amphetamine. Neuroscience 114, 925-933.
30. Ljung G, Box G (1978). On a measure of lack of fit in time series models. Biometrika 65, 297-303.
31. Lorrain DS, Arnold GM, Vezina P (2000). Previous exposure to amphetamine increases incentive to obtain the drug: long-lasting effects revealed by the progressive ratio schedule. Behavioural Brain Research 107, 9-19.
32. Markou A, Kosten TR, Koob GF (1998). Neurobiological similarities in depression and drug dependence : a self-medication hypothesis. Neuropsychopharmacology 18, 135-174.
33. Mason S, Graham N (2002). Areas beneath the relative operating characteristics (ROC) and relative operating levels (ROL) curves : statistical significance and interpretation. Quarterly Journal of the Royal Meteorological Society 128, 2145-2166.
34. Nestler EJ, Carlezon WA (2006). The mesolimbic dopamine reward circuit in depression. Biological Psychiatry 59, 1151-1159.
35. Nunes EV, Rounsaville BJ (2006). Comorbidity of substance use with depression and other mental disorders : from Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) to DSM-V. Addiction 101 (Suppl. 1), 89-96.
36. O'Brien ES, Legastelois R, Houchi H, Vilpoux C, et al. (2011). Fluoxetine, desipramine, and the dual antidepressant milnacipran reduce alcohol self-administration and/or relapse in dependent rats. Neuropsychopharmacology 36, 1518-1530.
37. Ohmori T, Abekawa T, Ito K, Koyama T (2000). Context determines the type of sensitized behaviour: a brief review and a hypothesis on the role of environment in behavioural sensitization. Behavioural Pharmacology 11, 211-221.
38. Pistovcakova J, Dostalek M, Sulcova A, Jezova D (2008). Tiagabine treatment is associated with neurochemical, immune and behavioural alterations in the olfactory bulbectomized rat model of depression. Pharmacopsychiatry 41, 54-59.
39. Raz S, Berger BD (2010). Effects of fluoxetine and PCPA on isolation-induced morphine self-administration and startle reactivity. Pharmacology, Biochemistry, and Behavior 96, 59-66.
40. Reichel CM, Murray JE, Grant KM, Bevins RA (2009). Bupropion attenuates methamphetamine self-administration in adult male rats. Drug and Alcohol Dependence 100, 54-62.
41. Reissner V, Kokkevi A, Schifano F, Room R, et al. (2011). Differences in drug consumption, comorbidity and health service use of opioid addicts across six European urban regions (TREAT-project). European Psychiatry, doi : 10.1016/j.eurpsy.2010.10.001, published online 31 January 2011.
42. Shuto T, Seeman P, Kuroiwa M, Nishi A (2008). Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1 and D2 receptors in methamphetamine-sensitized rats. European Journal of Neuroscience 27, 2551-2557.
43. Silva de Lima M, Farrell M, Lima Reisser AA, Soares B (2010). WITHDRAWN: antidepressants for cocaine dependence. Cochrane Database of Systematic Reviews, CD002950.
44. Slattery DA, Markou A, Cryan JF (2007). Evaluation of reward processes in an animal model of depression. Psychopharmacology 190, 555-568.
45. Song C, Leonard BE (2005). The olfactory bulbectomised rat as a model of depression. Neuroscience & Biobehavioral Reviews 29, 627-647.
46. Vieyra-Reyes P, Mineur YS, Picciotto MR, Tunez I, et al. (2008). Antidepressant-like effects of nicotine and transcranial magnetic stimulation in the olfactory bulbectomy rat model of depression. Brain Research Bulletin 77, 13-18.
47. Vinklerova J, Novakova J, Sulcova A (2002). Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251. Journal of Psychopharmacology 16, 139-143.
48. Wohl M, Ades J (2009). Depression and addictions: links and therapeutic sequence. La Revue du praticien 59, 484-487.
49. Wong EH, Yocca F, Smith MA, Lee CM (2010). Challenges and opportunities for drug discovery in psychiatric disorders : the drug hunters' perspective. International Journal of Neuropsychopharmacology 13, 1269-1284.
50. Yu DS, Smith FL, Smith DG, Lyness WH (1986). Fluoxetine-induced attenuation of amphetamine self-administration in rats. Life Sciences 39, 1383-1388.
51. Zellner MR, Watt DF, Solms M, Panksepp J (2011). Affective neuroscientific and neuropsychoanalytic approaches to two intractable psychiatric problems: why depression feels so bad and what addicts really want. Neuroscience and Biobehavioral Reviews 35, 2000-2008.